Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?

Neurol Neuroimmunol Neuroinflamm

From the Department of Neurology (C.M., T.F., E.F., E.M.), Dell Medical School, Austin, TX; and Department of Neurology and Program in Immunology (S.S.Z.), University of California, San Francisco, CA.

Published: September 2020

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309524PMC
http://dx.doi.org/10.1212/NXI.0000000000000811DOI Listing

Publication Analysis

Top Keywords

interferons front
4
front stage
4
stage essential
4
essential disease-modifying
4
disease-modifying therapy
4
therapy era
4
era coronavirus
4
coronavirus disease
4
disease 2019?
4
interferons
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!